The mutation of SPN, SPN-A566V, has an oncogenic effect since the expression of this mutation in breast cancer cell lines induces an increase in the tumorigenic and stemness properties of the cells depending on p53 mutations [80]. Here, SPN is linked to breast carcinoma.